The cardiorenal syndrome

Blood Purification

Volumn 27, Issue 1, 2009, Pages 114-126

  Ronco, Claudio ^a   Chionh, Chang Yin ^a   Haapio, Mikko ^b   Anavekar, Nagesh S ^c   House, Andrew ^e   Bellomo, Rinaldo ^d  

^a SAN BORTOLO HOSPITAL   (Italy)

^b Meilahti Hospital   (Finland)

^c NORTHERN HOSPITAL   (Australia)

^d AUSTIN HOSPITAL   (Australia)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Acute heart failure; Acute kidney injury; Cardiorenal syndrome; Cardiovascular risk; Chronic kidney disease; Heart kidney interaction; Renocardiac syndrome

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; VASODILATOR AGENT; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; CARDIOGENIC SHOCK; CARDIORENAL SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GLOMERULONEPHRITIS; GLOMERULOPATHY; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEPSIS; SYNDROME; ULTRAFILTRATION; UREMIA;

EID: 58849091322     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167018     Document Type: Conference Paper

References (85)

1. Dar O, Cowie MR: Acute heart failure in the intensive care unit: epidemiology. Crit Care Med 2008;36(1 suppl):S3-S8.
2. Schrier RW: Cardiorenal versus reno-cardiac syndrome: is there a difference? Nat Clin Pract Nephrol 2007;3:637.
3. Ronco C: Cardiorenal and reno-cardiac syndromes: clinical disorders in search of a systematic definition. Int J Artif Organs 2008;31:1-2.
4. Liang KV, Williams AW, Greene EL, Redfield MM: Acute decompensated heart failure and the cardio-renal syndrome. Crit Care Med 2008;36(suppl):S75-S88.
5. Ronco C, House AA, Haapio M: Cardio-renal syndrome: refining the definition of a complex symbiosis gone wrong. Intensive Care Med 2008;34:957-962.
6. Ronco C, Haapio M, House AA, et al: Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
7. Silverberg DS, Wexler D, Iaina A, et al: Anemia, chronic renal disease and congestive heart failure - The cardio-renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006;38:295-310.
8. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B: The severe cardio-renal syndrome:'Guyton revisited'. Eur Heart J 2005;26:11-17.
9. Kelly KJ: Acute renal failure: much more than a kidney disease. Semin Nephrol 2006;26:105-113.
10. Berl T, Henrich W: Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 2006;1:8-18.
11. Kramer BK, Schweds F, Riegger GA: Diuretic treatment and diuretic resistance in heart failure. Am J Med 1999;106:90-96.
12. Mebazaa A, Gheorghiade M, Pina IL, et al: Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. Crit Care Med 2008;36(suppl):S129-S139.
13. Haldeman GA: Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 1999;137:352-360.
14. Adams KF, Fonarow GC, Emerman CL, et al: Characteristics and outcome of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-216.
15. Fonarow GC, Gattis Stough W, Abraham WT, et al: Characteristics, treatments and outcomes of patients with preserved systolic function hospitalized for heart failure. J Am Coll Cardiol 2007;50:768-777.
16. Jose P, Skali H, Anavekar N, et al: Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. J Am Soc Nephrol 2006;17:2886-2891.
17. Goldberg A, Hammerman H, Petcherski S, et al: In-hospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction. Am Heart J 2005;150:330-337.
18. Tokuyama H, Kelly DJ, Zhang Y, et al: Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia. Nephron Physiol 2007;106:p54-p62.
19. Ellison DH: Diuretic resistance: physiology and therapeutics. Semin Nephrol 1999;19:581-597.
20. Almeshari K, Ahlstrom NG, Capraro FE, et al: A volume independent component to postdiuretic sodium retention in humans. J Am Soc Nephrol 1993;102:450-458.
21. Howard PA, Dunn MI: Aggressive diuresis for severe heart failure in the elderly. Chest 2001;119:607-610.
22. Opdam H, Wan L, Bellomo R: A pilot assessment of the FloTrac cardiac output monitoring sytem. Intensive Care Med 2007;133:344-349.
23. Mayer J, Boldt J, Wolf MW, Lang J, Sutton S: Cardiac output derived from arterial pressure waveform analysis in patients undergoing cardiac surgery. Validity of a second generation device. Anesth Analg 2008;106:867-872.
24. Wan L, Naka T, Uchino S, Bellomo R: A pilot study of pulse contour cardiac output monitoring in patients with septic shock. Crit Care Resusc 2005;7:165-169.
25. Nguyen BH, Losey T, Rasmussen BA, et al: Interrater reliability of cardiac output measurements by transcutaneous Doppler ultrasound: implications for non-invasive hemodynamic monitoring in the ED. Am J Emerg Med 2006;24:828-835.
26. Costanzo MR, Guglin ME, Saltzberg MT, et al: Ultrafiltration versus diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007;49:675-683.
27. Verma A, Solomon SD: Optimizing care of heart failure after acute myocardial infarction with an aldosterone receptor antagonist. Curr Heart Fail Rep 2007;4:183-189.
28. Chen ZM, Pan HC, Chen YP, et al: Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: a randomized placebo-controlled trial. Lancet 2005;366:1622-1632.
29. Yorgun H, Deniz A, Aytemir K: Cardiogenic shock secondary to combination of diltiazem and sotalol. Intern Med J 2008;38:221-222.
30. Tessone A, Gottlieb S, Barbash IM, et al: Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology 2007;108:193-199.
31. McCullough PA, Wolyn R, Rocher LL, et al: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375.
32. Damman K, Navis G, Voors AA, et al: Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail 2007;28:287-285.
33. Hillege HL, Nitsch D, Pfeffer MA, et al: Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671-678.
34. Bhatia RS, Tu JV, Lee DS, et al: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-269.
35. Jie KE, Verhaar MC, Cramer MJ, et al: Erythropoietin and the cardio-renal syndrome: cellular mechanisms on the cardio-renal connectors. Am J Physiol Renal Physiol 2006;291:F392-F344.
36. Palazzuoli A, Silverberg DS, Iovine F, et al: Effects of beta-erythropoietin treatment of left ventricular remodelling, systolic function, and B-type natriuretic peptide levels in patients with the cardio-renal anemia syndrome. Am Heart J 2007;154:e9-e15.
37. Butler J, Forman DE, Abraham WT, et al: Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004;147:331-339.
38. McCullough PA: Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 2002;3:71-76.
39. Wright RS, Reeder GS, Herzog CA, et al: Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-570.
40. Beattie JN, Soman SS, Sandberg KR, et al: Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001;37:1191-1200.
41. Gibson CM, Pinto DS, Murphy SA, et al: Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003;42:1535-1543.
42. Berger AK, Duval S, Krumholz HM: Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003;42:201-208.
43. French WJ, Wright RS: Renal insufficiency and worsened prognosis with STEMI: a call for action. J Am Coll Cardiol 2003;42:1544-1546.
44. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000;36(suppl 3):S24-S30.
45. Keltai M, Tonelli M, Mann JF, et al: Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. Eur J Cardiovasc Prev Rehabil 2007;14:312-318.
46. Ruggenenti P, Perna A, Remuzzi G: ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol 2001;12:2832-2837.
47. Fung JW, Szeto CC, Cahn JY, et al: Prognostic value of renal function in patients with cardiac resynchronization therapy. Int J Cardiol 2007;122:10-16.
48. Gheorghiade M, Niazi I, Ouyang J, et al: Vasorpessin-V-2 receptor blockade with tolvaptan in patients with chronic heart failure: results of a double-blind randomized trial. Circulation 2003;107:2690-2696.
49. Konstan MA, Gheorghiade M, Burnett JC Jr, et al: Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 2007;297:1319-1331.
50. Uchino S, Bellomo R, Goldsmith D, Bates S: An assessment of the RIFLE criteria for ARF in hospitalized patients. Crit Care Med 2006; 34:1913-1917.
51. Bagshaw SM, George C, Dinu I, Bellomo R: A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23:1203-1210.
52. Blake P, Hasegawa Y, Khosla MC, et al: Isolation of myocardial depressant factor(s) from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 1996;42:M911-M915.
53. Meyer TW, Hostetter TH: Uremia. N Engl J Med 2007;357:1316-1325.
54. United States Renal Data System. USRDS 2000 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2000, pp 583-689.
55. Brady JP, Hasbargen JA: A review of the effects of acidosis on nutrition in dialysis patients. Semin Dial 2000;13:252-255.
56. McCullough PA, Sandberg KR: Chronic kidney disease and sudden death: strategies for prevention. Blood Purif 2004;22:136-142.
57. Selby NM, McIntyre CW: The acute cardiac effects of dialysis. Semin Dial 2007;20:220-228.
58. Ronco C, Bellomo R, Ricci Z: Continuous renal replacement therapy in the critically ill patients. Nephrol Dial Transplant 2001;16(suppl):67-72.
59. Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050-1065.
60. Chertow GM, Normand SL, Silva LR, Mc-Neil BJ: Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. Am J Kidney Dis 2000;35:1044-1051.
61. Herzog CA: Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome? Nephrol Dial Transplant 2002;17:7-10.
62. Levey AS, Coresh J, Balk E, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
63. Johnson DW, Craven AM, Isbel NM: Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial Int 2007;11:1-14.
64. Logar CM, Herzog CA, Beddhu S: Diagnosis and therapy of coronary artery disease in renal failure, end-stage renal disease, and renal transplant populations. Am J Med Sci 2003;325:214-227.
65. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA: Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int 2003;87(suppl):S24-S31.
66. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
67. Coresh J, Astor BC, Greene T, et al: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1-12.
68. Garg AX, Clark WF, Haynes RB, House AA: Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 2002;61:1486-1494.
69. Keith DS, Nichol GA, Guillon CM, et al: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663.
70. Sarnak MJ, Coronado BE, Greene T, et al: Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002;57:327-335.
71. al Suwaidi J, Reddan DN, Williams K, et al: Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;106:974-980.
72. Hobbach HP, Gibson CM, Giugliano RP, et al: The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction. J Thromb Thrombolysis 2003;16:167-174.
73. Al Ahmad A, Rand WM, Manjunath G, et al: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-962.
74. Sorensen CR, Brendorp B, Rask-Madsen C, et al: The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002;23:948-952.
75. Tokmakova MP, Skali H, Kenchaiah S, et al: Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Circulation 2004;110:3667-3673.
76. Anavekar NS, McMurray JJ, Velazquez EJ, et al: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295.
77. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW: Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-1009.
78. Hjalmarson A, Goldstein S, Fegerberg B, et al: Effects of controlled-release metoprolol on total mortality, hospitalization, and well-being in patients with heart failure. JAMA 2000;283:1295-1302.
79. Cunningham PN, Dyanov HM, Park P, et al: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF-1 receptors in kidney. J Immunol 2007;168:5817-5823.
80. Kumar A, Paladugu B, Mensing J, Kumar A, Parrillo JE: Nitric oxide-dependent and independent mechanisms are involved in TNF-alpha induced depression of cardiac myocyte contractility. Am J Physiol Regul Integr Comp Physiol 2007;292:R1900-R1906.
81. Honore PM, Jamez J, Wauthier M, et al: Prospective evaluation of short-term high-volume hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
82. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; the ADQI workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-R212.
83. Duke GJ: Renal protective agents: a review. Crit Care Resusc 1999;1:265-275.
84. Bagshaw SM, Delaney A, Haase M, et al: Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 2007;9:60-68.
85. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139.